Human Aggrecan G1-IGD-G2 Domains Antibody Summary
Val20-Arg675
Accession # NP_037359
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Aggrecan in Rat Mesenchymal Stem Cells. Aggrecan was detected in immersion fixed rat mesenchymal stem cells differentiated to chondrocytes using Goat Anti-Human Aggrecan G1-IGD-G2 Domains Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1220) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conju-gated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Cells on Coverslips.
View Larger
Aggrecan in Human Cartilage. Aggrecan was detected in immersion fixed paraffin-embedded sections of human cartilage using 15 µg/mL Goat Anti-Human Aggrecan G1-IGD-G2 Domains Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1220) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
View Larger
Detection of Porcine Aggrecan by Immunocytochemistry/ Immunofluorescence In vitro differentiation capacity of young and old BM-MSCs: (A) Representative micrographs from each experimental group showing morphological change after 21 days of differentiation. (B) Results of adipogenic, osteogenic and chondrogenic differentiation. Representative micrographs showing anti-FABP4, Oil Red O, anti-osteocalcin, Alizarin Red-S and anti-aggrecan staining in cultured BM-MSCs from each experimental group. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/21992089), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Aggrecan
Aggrecan, also known as aggrecan 1, chondroitin sulfate proteoglycan, and large aggregating proteoglycan, is encoded by the AGC1 gene with gene aliases of SEDK; CSPG1; MSK16; CSPGCP. As the key component of the cartilage extracellular matrix, aggrecan hydrates the collagen network and provides cartilage with its properties of compressibility and elasticity. Maintenance of aggrecan content is therefore critical to the function of the tissue and aggrecan degradation is an important factor in the erosion of articular cartilage in arthritic diseases (2). The deduced amino acid sequence of human aggrecan core protein consists of 2415 resides and predicts a signal peptide and domains of G1, IGD, G2, KS, CS-1, CS-2, and G3 (3). Two globular domains, G1 and G2, comprise the N-terminus of the proteoglycan and also contain link domains. The third globular domain, G3, corresponds to the C-terminus. The keratan sulfate (KS) and the chondroitin sulfate (CS) attachment domains are between G2 and G3. With KS and CS attached to the 250 kDa core protein, aggrecan monomers exist as a 1,000-2,000 kDa molecule. In addition, aggrecan monomers interact with hyaluronan through their G1 domain, resulting in larger aggregates containing 10-100 aggrecan monomers on a hyaluronan backbone (2).
Aggrecan can be cleaved by MMPs and ADAMTSs at the Asn360-Phe361 and Glu392-Ala393 bond in the IGD (residues are numbered based on Accession # NP_037359), respectively (2). Inhibition of ADATMS4 and ADAMTS5 cleavage prevents aggrecan degradation in osteoarthritic cartilage, while mice with aggrecan resistant to MMP cleavage do not accumulate aggrean and develop normally (2, 4). Consisting of the G1, IGD and G2 domains, rhAggrecan can be used as a protein substrate for MMPs and ADAMTSs and in binding assays involving hyaluronan.
- Doege. K.J. et al. (1991) J. Biol. Chem. 266:894.
- Malfait, A-M. et al. (2002) J. Biol. Chem. 277:22201.
- Caterson, B. et al. (2000) Matrix Biol. 19:333.
- Little, C.B. et al. (2005) Mol. Cel. Biol. 25:3388.
Product Datasheets
Citations for Human Aggrecan G1-IGD-G2 Domains Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
19
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Single-cell atlas unveils cellular heterogeneity and novel markers in human neonatal and adult intervertebral discs
Authors: Wensen Jiang, Juliane D. Glaeser, Khosrowdad Salehi, Giselle Kaneda, Pranav Mathkar, Anton Wagner et al.
iScience
-
Fibrillin-2 is a key mediator of smooth muscle extracellular matrix homeostasis during mouse tracheal tubulogenesis
Authors: Wenguang Yin, Hyun-Taek Kim, ShengPeng Wang, Felix Gunawan, Rui Li, Carmen Buettner et al.
European Respiratory Journal
-
Cholinergic-like neurons and cerebral spheroids bearing the PSEN1 p.Ile416Thr variant mirror Alzheimer's disease neuropathology
Authors: Gomez-Sequeda, N;Mendivil-Perez, M;Jimenez-Del-Rio, M;Lopera, F;Velez-Pardo, C;
Scientific reports
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Directed differentiation of human iPSCs into mesenchymal lineages by optogenetic control of TGF-? signaling
Authors: Wu, JY;Yeager, K;Tavakol, DN;Morsink, M;Wang, B;Soni, RK;Hung, CT;Vunjak-Novakovic, G;
Cell reports
Species: Human
Sample Types: Spheroids
Applications: IHC -
Characterization and Advancement of an Evaluation Method for the Treatment of Spontaneous Osteoarthritis in STR/ort Mice: GRGDS Peptides as a Potential Treatment for Osteoarthritis
Authors: Chen, MF;Hu, CC;Hsu, YH;Chiu, YT;Chen, KL;Ueng, SWN;Chang, Y;
Biomedicines
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC -
Hyaluronic acid hydrogels support to generate integrated bone formation through endochondral ossification in vivo using mesenchymal stem cells
Authors: S Yamazaki, R Hirayama, Y Ikeda, S Iseki, T Yoda, MA Ikeda
PLoS ONE, 2023-02-02;18(2):e0281345.
Species: Human
Sample Types: Recombinant Protein
Applications: Western Blot -
Does TBC1D4 (AS160) or TBC1D1 Deficiency Affect the Expression of Fatty Acid Handling Proteins in the Adipocytes Differentiated from Human Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Obtained from Subcutaneous and Visceral Fat Depots?
Authors: A Mik?osz, B ?ukaszuk, E Supruniuk, K Grubczak, M Moniuszko, B Choroma?sk, P My?liwiec, A Chabowski
Cells, 2021-06-16;10(6):.
Species: Human
Sample Types: Whole Cells
Applications: IHC -
Stabilization of heterochromatin by CLOCK promotes stem cell rejuvenation and cartilage regeneration
Authors: C Liang, Z Liu, M Song, W Li, Z Wu, Z Wang, Q Wang, S Wang, K Yan, L Sun, T Hishida, Y Cai, JCI Belmonte, P Guillen, P Chan, Q Zhou, W Zhang, J Qu, GH Liu
Cell Res., 2020-07-31;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Cleavage of proteoglycans, plasma proteins and the platelet-derived growth factor receptor in the hemorrhagic process induced by snake venom metalloproteinases
Authors: AF Asega, MC Menezes, D Trevisan-S, D Cajado-Car, L Bertholim, AK Oliveira, A Zelanis, SMT Serrano
Sci Rep, 2020-07-31;10(1):12912.
Species: Mouse
Sample Types: Cell Lysates, Tissue Homogenates
Applications: Western Blot -
Human mesenchymal stem cells are resistant to UV-B irradiation
Authors: R Lopez Pere, J Brauer, A Rühle, T Trinh, S Sisombath, P Wuchter, AL Grosu, J Debus, R Saffrich, PE Huber, NH Nicolay
Sci Rep, 2019-12-27;9(1):20000.
Species: Human
Sample Types: Spheroid
Applications: IHC-Fr -
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist
Authors: S Vander Bek, JC de Vries, B Meier-Schi, P Meyer, D Jiang, A Sindrilaru, FF Ferreira, A Hainzl, S Schatz, J Muschhamme, NJ Scheurmann, P Kampilafko, AM Seitz, L Dürselen, A Ignatius, MA Kluth, C Ganss, M Wlaschek, K Singh, P Maity, NY Frank, MH Frank, K Scharffett
Stem Cells, 2019-05-13;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Effects of sesamin on chondroitin sulfate proteoglycan synthesis induced by interleukin-1beta in human chondrocytes
Authors: W Srisuthtay, D Pruksakorn, P Kongtawele, P Pothacharo
BMC Complement Altern Med, 2017-05-31;17(1):286.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Identification of multipotent stem cells in human brain tissue following stroke
Authors: K Tatebayash, Y Tanaka, A Nakano-Doi, R Sakuma, S Kamachi, M Shirakawa, K Uchida, H Kageyama, T Takagi, S Yoshimura, T Matsuyama, T Nakagomi
Stem Cells Dev, 2017-04-19;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
MSC from fetal and adult lungs possess lung-specific properties compared to bone marrow-derived MSC.
Authors: Rolandsson Enes S, Andersson Sjoland A, Skog I, Hansson L, Larsson H, Le Blanc K, Eriksson L, Bjermer L, Scheding S, Westergren-Thorsson G
Sci Rep, 2016-07-06;6(0):29160.
Species: Human
Sample Types: Whole Cells, Whole Tissue
Applications: ICC, IHC -
Gene expression profile analysis of human mesenchymal stem cells from herniated and degenerated intervertebral discs reveals different expression of osteopontin.
Authors: Marfia G, Navone S, Di Vito C, Tabano S, Giammattei L, Di Cristofori A, Gualtierotti R, Tremolada C, Zavanone M, Caroli M, Torchia F, Miozzo M, Rampini P, Riboni L, Campanella R
Stem Cells Dev, 2014-10-29;24(3):320-8.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.
Authors: Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S
PLoS ONE, 2013-01-29;8(1):e55319.
Species: Human
Sample Types: Whole Cells
Applications: IHC-Fr -
Age-related changes in rat bone-marrow mesenchymal stem cell plasticity.
Authors: Asumda FZ, Chase PB
BMC Cell Biol., 2011-10-12;12(0):44.
Species: Rat
Sample Types: Whole Cells
Applications: ICC -
Effect of functionalised fluorescence-labelled nanoparticles on mesenchymal stem cell differentiation.
Authors: Tautzenberger A, Lorenz S, Kreja L, Zeller A, Musyanovych A, Schrezenmeier H, Landfester K, Mailander V, Ignatius A
Biomaterials, 2009-12-11;31(8):2064-71.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Safety and efficacy of human juvenile chondrocyte-derived cell sheets for osteochondral defect treatment
Authors: Makoto Kondo, Sumako Kameishi, Kyungsook Kim, Nicolas F. Metzler, Travis G. Maak, Douglas T. Hutchinson et al.
npj Regenerative Medicine
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human Aggrecan G1-IGD-G2 Domains Antibody
There are currently no reviews for this product. Be the first to review Human Aggrecan G1-IGD-G2 Domains Antibody and earn rewards!
Have you used Human Aggrecan G1-IGD-G2 Domains Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
